Johnson & Johnson Common Stock (JNJ): M&A News

JNJ – Actelion/Johnson & Johnson offer concessions to the EU for their pending merger; provisional deadline – 6/12/17.

Key Facts Surrounding This News Item

  • JNJ had a POWR Rating of A (Strong Buy) coming into today.
  • JNJ was 1.74% above its 10-Day Moving Average coming into today.
  • JNJ was 2.32% above its 20-Day Moving Average coming into today.
  • JNJ was 1.46% above its 50-Day Moving Average coming into today.
  • JNJ was 5.24% above its 100-Day Moving Average coming into today.
  • JNJ was 7.19% above its 200-Day Moving Average coming into today.
  • JNJ had returned +10.67% year-to-date leading up to today’s news, versus a +5.96% return from the benchmark S&P 500 during the same period.

More Info About Johnson & Johnson Common Stock (JNJ)

Johnson & Johnson researches and develops, manufactures, and sells various products in the health-care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. Some of its well-known brands include Tylenol-fever, Listerine-bad breath, Splenda-no-calorie sweetener, Neutrogena-skin care, Pepcid-heartburn, Zyrtec – allergy, Motrin-ibuprofen, Sudafed-allergy, and plenty more. The company was founded in 1885 and is based in New Brunswick, New Jersey. View our full JNJ ticker page with ratings, news, and more.

JNJ at a Glance

JNJ Current POWR Rating™
Overall POWR Rating™
JNJ Current Price $142.60 1.03%
More JNJ Ratings, Data, and News

JNJ Price Reaction

The day of this event (May. 18, 2017)
JNJ Closing Price$124.57 0.24%
JNJ Volume6,697,620
3.42% from avg
Leading up to this event
JNJ 1-mo return3.98%
After this event
JNJ 1-day return0.26%
JNJ 3-day return0.67%
JNJ 5-day return1.33%

JNJ Price Chart

More Johnson & Johnson Common Stock (JNJ) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All JNJ News
Page generated in 1.3489 seconds.